We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Platelet Indices Are Associated with Syphilis Activities

By LabMedica International staff writers
Posted on 11 May 2022

Syphilis is caused by Treponema pallidum, which is a chronic sexually transmitted disease that has highly variable clinical courses and manifestations from a painless chancre to severe damage in the brain, heart, and other organs. More...

Platelet indices have been reported as the important mediators in many infectious diseases. Platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) are the most commonly used indicators to evaluate platelet activation and function.

Venereologists at the Tongji University School of Medicine (Shanghai, China) and their colleagues conducted a retrospective cohort study the Shanghai Skin Disease Hospital from January 2015 to May 2021. A total of 2,061 patients with syphilis (425 primary and secondary syphilis, 433 latent syphilis, 463 serofast syphilis, 350 asymptomatic neurosyphilis, and 390 symptomatic neurosyphilis, respectively) were enrolled. Among them, 209 patients with neurosyphilis were followed until the end of the treatment. In addition, 528 healthy controls were enrolled during the study, with matched age and sex.

The data of platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and indicators of syphilis activities were collected. The correlations between the platelet indices and disease activities were analyzed. Data of erythrocyte sedimentation rate (ESR), C-reactive protein CRP, serum rapid plasma reagin (RPR), cerebrospinal fluid- venereal disease research laboratory (CSF VDRL), CSF- white blood cell (CSF-WBC) count, and CSF-protein concentration were collected from patients’ medical records.

The scientists reported that compared with the healthy controls, PLT was significantly increased in the primary and secondary syphilis group; whereas, MPV and PDW were significantly decreased in all stages of syphilis. These changes of platelet indices were reversed after anti-treponemal therapy. Further correlation analysis showed that PLT was positively associated with the syphilis activity indicators: RPR titer, CSF-WBC, CSF-protein, and CSF-VDRL and inflammatory markers: WBC, CRP, and ESR. Conversely, PDW was negatively correlated with all of these parameters. MPV had an inverse relationship with RPR, ESR, and CRP.

The authors concluded that their study provided the first evidence that platelet indices are associated with the disease activities in patients with syphilis. As the modification of platelet indices reflects the change of function, this study may suggest the foundation for further elucidation of the underlying mechanism of how platelets participate in the inflammatory response and pathogenesis of syphilis. The study was published on May 1, 2022 in the International Journal of Infectious Diseases.

Related Links:
Tongji University School of Medicine 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.